HIBASOLTANE: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
HIBASOLTANE
Largest movements
- Cash -€704
down €704 (-41.5%), from €1,697 to €993
mainly Net result for the year (-€826)
- Profit (loss) carried forward -€826
down €826 (-5.5%), from -€14,875 to -€15,700
- Trade debts +€122
up €122 (+15.5%), from €785 to €907
- Other operating charges +€429
up €429 (+111.7%), from €384 to €814
- Gross operating margin -€133
down €133 (-80.1%), from €166 to €33
- Financial income -€102
down €102 (-98.9%), from €103 to €1
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €3,810 | €3,107 | -€704 | -18.5% |
| Fixed assets | 21/28 | €82 | €82 | = | 0.0% |
| Financial fixed assets | 28 | €82 | €82 | = | 0.0% |
| Current assets | 29/58 | €3,729 | €3,025 | -€704 | -18.9% |
| Amounts receivable within one year | 40/41 | €1,998 | €1,998 | = | 0.0% |
| Other amounts receivable | 41 | €1,998 | €1,998 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €1,697 | €993 | -€704 | -41.5% |
| Deferred charges and accrued income | 490/1 | €35 | €35 | = | 0.0% |
| Total equity and liabilities | 10/49 | €3,810 | €3,107 | -€704 | -18.5% |
| Equity | 10/15 | €3,025 | €2,200 | -€826 | -27.3% |
| Contributions | 10/11 | €17,900 | €17,900 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€14,875 | -€15,700 | -€826 | -5.5% |
| Amounts payable | 17/49 | €785 | €907 | +€122 | +15.5% |
| Amounts payable within one year | 42/48 | €785 | €907 | +€122 | +15.5% |
| Trade debts | 44 | €785 | €907 | +€122 | +15.5% |
| Suppliers | 440/4 | €785 | €907 | +€122 | +15.5% |
| Other operating charges | 640/8 | €384 | €814 | +€429 | +111.7% |
| Gross operating margin | 9900 | €166 | €33 | -€133 | -80.1% |
| Operating profit (loss) | 9901 | -€219 | -€781 | -€562 | -257.0% |
| Financial income | 75/76B | €103 | €1 | -€102 | -98.9% |
| Recurring financial income | 75 | €103 | €1 | -€102 | -98.9% |
| Financial charges | 65/66B | €45 | €46 | +€1 | +1.7% |
| Recurring financial charges | 65 | €45 | €46 | +€1 | +1.7% |
| Profit (loss) for the period before taxes | 9903 | -€161 | -€826 | -€665 | -413.2% |
| Profit (loss) for the period | 9904 | -€161 | -€826 | -€665 | -413.2% |
| Profit (loss) for the period to be appropriated | 9905 | -€161 | -€826 | -€665 | -413.2% |
Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.